Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Abramson

Showing results (81-90 of 443) with videos related to

Pageof 45
Sort By:
Leukemia & Lymphoma|July 20, 2022
CAR T-cells in relapsed Burkitt lymphoma - a promising test drive in a rare diseaseJ Erika Haydu, Jeremy S Abramson
The American Journal of Emergency Medicine|March 1, 1984
Interposed abdominal compression CPR (IAC-CPR): a glimmer of hopeN G Bircher, N S Abramson
The New England Journal of Medicine|November 23, 2017
More on Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell LymphomaJeremy S Abramson, Yi-Bin Chen
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Recent advances in the treatment of non-Hodgkin's lymphomasJeremy S Abramson, Andrew D Zelenetz
Reviews of Infectious Diseases|March 1, 1988
Depression of neutrophil function induced by viruses and its role in secondary microbial infectionsJ S Abramson, E L Mills
Leukemia & Lymphoma|July 3, 2020
Patient selection for chimeric antigen receptor (CAR) T-cell therapy for aggressive B-cell non-Hodgkin lymphomasP Connor Johnson, Jeremy S Abramson
The Journal of Infectious Diseases|February 1, 1985
Persistence of Neisseria meningitidis in the upper respiratory tract after intravenous antibiotic therapy for systemic meningococcal diseaseJ S Abramson, J S Spika
Current Opinion in Hematology|May 24, 2016
Chemotherapy-sparing treatment strategies for follicular lymphoma: current options and future directionsSamuel Y Ng, Jeremy S Abramson
Blood|April 28, 2005
Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approachJeremy S Abramson, Margaret A Shipp
JAMA|February 2, 2002
US Immunization PolicyJon S Abramson, Larry K Pickering
Pageof 45

Showing results (81-90 of 443) with videos related to

Sort By:
Pageof 45
Leukemia & Lymphoma|July 20, 2022
CAR T-cells in relapsed Burkitt lymphoma - a promising test drive in a rare diseaseJ Erika Haydu, Jeremy S Abramson
The American Journal of Emergency Medicine|March 1, 1984
Interposed abdominal compression CPR (IAC-CPR): a glimmer of hopeN G Bircher, N S Abramson
The New England Journal of Medicine|November 23, 2017
More on Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell LymphomaJeremy S Abramson, Yi-Bin Chen
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Recent advances in the treatment of non-Hodgkin's lymphomasJeremy S Abramson, Andrew D Zelenetz
Reviews of Infectious Diseases|March 1, 1988
Depression of neutrophil function induced by viruses and its role in secondary microbial infectionsJ S Abramson, E L Mills
Leukemia & Lymphoma|July 3, 2020
Patient selection for chimeric antigen receptor (CAR) T-cell therapy for aggressive B-cell non-Hodgkin lymphomasP Connor Johnson, Jeremy S Abramson
The Journal of Infectious Diseases|February 1, 1985
Persistence of Neisseria meningitidis in the upper respiratory tract after intravenous antibiotic therapy for systemic meningococcal diseaseJ S Abramson, J S Spika
Current Opinion in Hematology|May 24, 2016
Chemotherapy-sparing treatment strategies for follicular lymphoma: current options and future directionsSamuel Y Ng, Jeremy S Abramson
Blood|April 28, 2005
Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approachJeremy S Abramson, Margaret A Shipp
JAMA|February 2, 2002
US Immunization PolicyJon S Abramson, Larry K Pickering
Pageof 45